AGL 40.02 Increased By ▲ 0.02 (0.05%)
AIRLINK 127.31 Increased By ▲ 0.27 (0.21%)
BOP 6.60 Decreased By ▼ -0.07 (-1.05%)
CNERGY 4.49 Decreased By ▼ -0.02 (-0.44%)
DCL 8.59 Increased By ▲ 0.04 (0.47%)
DFML 41.79 Increased By ▲ 0.35 (0.84%)
DGKC 87.70 Increased By ▲ 0.85 (0.98%)
FCCL 32.64 Increased By ▲ 0.36 (1.12%)
FFBL 65.02 Increased By ▲ 0.22 (0.34%)
FFL 10.26 Increased By ▲ 0.01 (0.1%)
HUBC 109.69 Increased By ▲ 0.12 (0.11%)
HUMNL 14.70 Increased By ▲ 0.02 (0.14%)
KEL 5.12 Increased By ▲ 0.07 (1.39%)
KOSM 7.57 Increased By ▲ 0.11 (1.47%)
MLCF 41.41 Increased By ▲ 0.03 (0.07%)
NBP 59.70 Decreased By ▼ -0.71 (-1.18%)
OGDC 193.80 Increased By ▲ 3.70 (1.95%)
PAEL 28.40 Increased By ▲ 0.57 (2.05%)
PIBTL 7.79 Decreased By ▼ -0.04 (-0.51%)
PPL 151.75 Increased By ▲ 1.69 (1.13%)
PRL 26.44 Decreased By ▼ -0.44 (-1.64%)
PTC 16.17 Increased By ▲ 0.10 (0.62%)
SEARL 84.00 Decreased By ▼ -2.00 (-2.33%)
TELE 7.64 Decreased By ▼ -0.07 (-0.91%)
TOMCL 35.52 Increased By ▲ 0.11 (0.31%)
TPLP 8.10 Decreased By ▼ -0.02 (-0.25%)
TREET 16.08 Decreased By ▼ -0.33 (-2.01%)
TRG 52.63 Decreased By ▼ -0.66 (-1.24%)
UNITY 26.38 Increased By ▲ 0.22 (0.84%)
WTL 1.25 Decreased By ▼ -0.01 (-0.79%)
BR100 9,953 Increased By 69.4 (0.7%)
BR30 30,908 Increased By 307.7 (1.01%)
KSE100 93,785 Increased By 429.6 (0.46%)
KSE30 29,050 Increased By 119.3 (0.41%)

Pfizer voiced hope Thursday it could roll out up to 20 million doses of a COVID-19 vaccine it is developing with German firm Biontech for emergency use by the end of 2020Pfizer.

The two companies are working on four possible vaccines against the new coronavirus, and launched clinical trials using volunteers in Germany earlier this month.

The head of the US pharma giant's vaccines unit, Nanette Cocero, told a virtual briefing Thursday that the companies were moving forward to ramp up clinical trials and manufacturing capabilities in parallel to be able to produce a large number of doses as soon as a vaccine is demonstrated to be safe and efficient.

It can take years for a new vaccine to be licensed for general use, but in the face of the COVID-19 pandemic, experimental vaccines shown to be safe and effective against the novel coronavirus could likely win approval for emergency use. The virus, which first surfaced in China late last year, has killed nearly 230,000 people and infected close to 3.2 million worldwide, according to a tally from official sources compiled by AFP.

Copyright Agence France-Presse, 2020

Comments

Comments are closed.